ACUVUE^® OASYS 2-Week for ASTIGMATISM

*ClinicalTrials.gov is a website maintained by the NIH. The 29 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE^® OASYS Brand 2-week family, ACUVUE^® OASYS 1-Day Brand family, and ACUVUE^® OASYS MAX 1-Day Brand family of contact lenses, vs. competitors’ products. Review conducted as of April 30, 2024.

^#Helps protect against transmission of harmful UV radiation to the cornea and into the eye. WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

‖MyACUVUE^® is subject to Terms of Use which can be viewed upon downloading the app. Alternatively, you may email [email protected] for a copy.

MyACUVUE^® is only available at selected Optical Practices which you can find in the above Practice Locator.

§Survey among 1,005 Eye Care Professionals from the United States, United Kingdom, Japan, South Korea, China, France, and Germany conducted 11/2023 to 12/2023.

¶The names and optometrist profiles on this site are provided for informational purposes only and do not represent an endorsement of any particular healthcare professional. The choice of optometrist and particular treatment options belongs to you.

1. Data on file 2024, ACUVUE^® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
2. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
3. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE OASYS vs. ULTRA, n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period.
4. Tarantino N, Kao E, Huang L, et al. A clinical safety and acceptability evaluation of a novel multi-purpose disinfecting solution [abstract 60]. In: Abstracts of the 34th BCLA Annual Clinical Conference, Birmingham, 2010. Contact Lens Anterior Eye. 2010;33(6):256-300. doi: 10.1016/j.clae.2010.07.002.
5. Tilia D, Lazon de la Jara P, Weng R, et al. Clinical evaluation of a new contact lens solution when used in conjunction with two silicone hydrogel lenses during short term wear [abstract 31]. In: Abstracts of the 34th BCLA Annual Clinical Conference, Birmingham, 2010.Contact Lens Anterior Eye. 2010;33(6):256-300. doi: 10.1016/j.clae.2010.07.002.

Important information for contact lens wearers: ACUVUE^® Brand Contact Lenses are available by prescription only for vision correction. An Eye Care Professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your optometrist. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, contact your optometrist immediately. For more information on proper wear, care and safety, talk to your optometrist and ask for a Patient Instruction Guide or call the ACUVUE^® Support Team on 0800 466 173.